Roche (OTCMKTS:SNYNF) Rating Reiterated by Jefferies Financial Group

Share on StockTwits

Jefferies Financial Group reiterated their buy rating on shares of Roche (OTCMKTS:SNYNF) in a research report released on Wednesday, reports. They currently have a $95.00 target price on the stock.

Shares of SNYNF stock remained flat at $$85.65 on Wednesday. The company had a trading volume of 70 shares.

Roche Company Profile

Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia in adults and children; and Cablivi to treat acquired thrombotic thrombocytopenic purpura in adults.

Featured Story: How is a buy-side analyst different from a sell-side analyst?

Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with's FREE daily email newsletter.